Researchers have been excited about this new drug, a innovative dual agonist showing remarkable outcomes in clinical trials for size management. It functions by modulating several pathways : GLP-1 and GIP, that , when stimulated, assist regulate hunger and boost energy expenditure . Preliminary reports demonstrate substantial body management and po